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Chest pain is amajor cause of admission to an emergency department
[1,2]. Erroneous discharge from the emergency department has been
reported earlier [3–5]. Since 2008, more than 130 CPUs in Germany have
been certiﬁed by the German Cardiac Society [6] and the German CPU
Registrywas implemented. The goal is the validation of the quality of care,
including benchmark reports and risk-adjusted comparisons in a
prospective fashion. We compared troponin positive (Trop+) with
troponin negative (Trop−) patients.
The registry prospectively enrolled 11,656 patients admitted to one of
the 38 participating CPUs between December 1st 2008 and August 18th
2011. Follow-up was attained from 5313 patients. The diagnostic
algorithm was based on the detection of cardiac troponin above the
99th percentile of the upper reference limit with a rise and/or fall [7].
Troponin assays used in clinical routine included 4th generation cardiac
troponin T (20.3%), high sensitive (hs) troponin T (14.5%), or troponin I
(65.2%) without further differentiation into different manufacturers.
Baseline characteristics are shown in Table 1a. Patients that initially were
Trop− but developed a troponin subsequently (n= 544)were similar to
the Trop+groupwith 64%male patients, 34% smokers, 30% diabetes, 80%
hypertension, and 48% dyslipidemia.
Both, times from begin of symptoms until hospitalization (9 h 07 min
vs. 7 h 40min) and times from ﬁrst medical contact to hospitalization
(1 h 08 min vs. 51 min) were signiﬁcantly longer in the Trop+ than the
Trop− group (p b 0.01, respectively).
In the Trop+ group signiﬁcantly more patients complained about
chest pain (i.e. angina pectoris) and dyspnea (Fig.1a). Again, patients that
initially were Trop− but developed a troponin subsequently were similar
to the Trop+ group with 90% having angina pectoris. A pre-hospital ECG
was rarely done, i.e. in only 20% of Trop+ patients but still more often
than in Trop− patients (11%, p b 0.01). In these pre-hospital ECGs, we
found more frequent ST-segment elevations and depressions in the
Trop+ as compared to the Trop− group. Similarly, an ECG recorded
within 5 min after presentation to the CPU showed ECG changes more
often in the Trop+ patients (Fig. 1b).
Among all patients admitted to the CPU an acute coronary syndrome
(ACS) was the most frequent diagnosis (41%), including ST-elevation
myocardial infarction (STEMI), non-ST-elevation myocardial infarction
(NSTEMI), and unstable angina pectoris (UAP). In 83% of patients in the
Trop+ group an ACS was the primary diagnosis as compared to only 28%
in the Trop− group (p b 0.01). Other diagnoses were less frequent but
more often found in the Trop− group except for peri-/myocarditis
(Fig. 2a).
Coronary interventions were much more frequent in the Trop+
patients (Fig. 2b). The median time interval from hospital admittance to
intervention was exactly 5 h for Trop+ patients as compared to 22 h
29 min for Trop− patients (p b 0.01). Also, the stay in the CPUwasmuch
longer in Trop+ patients than in Trop− patients (31 h 16 min vs. 7 h
26 min, p b 0.01). More patients were dismissed directly home from the
CPU in the Trop− group (34.7% vs. 22.0% Trop+, p b 0.01). Of note,
patients that initially were Trop− but developed troponin subsequently
were similar to the Trop+ groupwith 84% having an angiogram and 58%
treated with a PCI.
Mortality rates in theCPUswere very low.Nevertheless,more Trop+
than Trop− patients died (0.7% vs. 0.1%, p b 0.01). Of all patients
considered to have suffered an ACS, MACCE (including death,
myocardial infarction, and stroke) occurred more often in the Trop+
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Table 1a
Baseline characteristics. Baseline characteristics of Trop+ and Trop− patients included in
the German CPU Registry. All values are in %, except for age in years (median and quartile).
CVD = cardiovascular disease, PCI = percutaneous coronary intervention,
CABG =coronary artery bypass graft, PVD = peripheral vascular disease, and
ICD = implantable cardioverter deﬁbrillator.
Trop+ (n = 2853) Trop− (n = 8803) p
Age (years) 70.0 (58.1–78.0) 67.5 (54.9–76.1) b0.01
Male 67% 58% b0.01
Smoking 32% 25% b0.01
Diabetes 29% 20% b0.01
Hypertension 77% 72% b0.01
Dyslipidemia 45% 42% b0.01
Family history 20% 24% b0.01
Known CVD 58% 65% b0.01
Prior PCI 27% 38% b0.01
Prior CABG 13% 11% b0.01
Prior stroke 6% 5% =0.08
PVD 8% 6% b0.01
Chronic kidney disease 13% 7% b0.01
Heart failure 11% 9% b0.01
ICD or pacemaker 7% 9% b0.01
1651Letters to the Editor
than in the Trop− group (9.5% vs. 1.4%; p b 0.01). Of note, patients that
initiallywere Trop− but developed troponin subsequently were similar
to the Trop+groupwith 0.6%died in the CPUwith aMACCE rate of 8.1%.
Interestingly, nodifferencebetween severe (0.6% vs. 0.2%, p = 0.09) and
moderate (0.9% vs. 0.5%, p = 0.18) bleedings were found between
Trop+ and Trop− patients.
Follow-up was attained from 46% of all patients almost half of whom
were previously diagnosedwith ACS during index admission (n= 2519).
The percentage of Trop+ patients reached at follow-up was somewhat
higher with 52% of whom 86% had a previous ACS. In contrast, follow-up
was less successful in Trop− patients with 44% of whomonly 32% had an
ACS. At follow-up after 3 months, independently of ACS 7.6% of Trop+
patients (n= 112) had died vs. 3.1% (n= 118) of Trop− patients
(p b 0.01). Interestingly, those patients who were dismissed directly
home from the CPU had a much smaller incidence of death with 1.4% for
Trop+ patients and 0.6% for Trop− patients. Death occurred after
26 days (8–77 days) in the Trop+ group compared to 38 days (11–
110 days) in the Trop− group (p b 0.05). The cause of death was not
different between Trop+ vs. Trop− patients, including sudden death
(13% vs. 22%, p = 0.17), cardiovascular death (46% vs. 36%, p = 0.27),
non-cardiovascular (33% vs. 38%, p = 0.53), or unknown (8.2% vs. 3.6%,
p = 0.28).
However, it is interesting to know that Trop+ patients that had died
during the 3 month follow-up had more often a history of cardiovascular
disease (87%) as compared to Trop+ survivors (53%, p b 0.01), a clearly
higher GRACE risk score for intrahospital mortality of 5.2% vs.1.6% (and at
6 month of 9.1% vs. 2.9%, respectively), were less often interventionally
treatedwith 36% vs. 71% (PCI or bypass), and thus treatedmore often only
withmedication (56% vs. 24%, p b 0.01). Of note, Trop− patients that had
died during the 3 month follow-up only had aGRACE risk score of 2.1% for
intrahospital mortality (and 3.7% for 6 month mortality, respectively).
There was no difference in the percentage of patients that was
interventionally treated or treated only with medication as compared
to the Trop− survivors.
At 3 months follow-up,MACCE had occurred in 11% of Trop+patients
(n= 150) vs. 5% of Trop− patients (n= 171) (p b 0.01). Interestingly,
those patients who were dismissed directly home from the CPU had a
much lower MACCE rate of 4.4% for Trop+ patients and 1.3% for Trop−
patients. Revascularizationwas needed in 14% of Trop+patients vs. 7% of
Trop− patients (p b 0.01). 29% of Trop+ patients and 23% of Trop−
patients were rehospitalized within 3 months (p b 0.01). Readmission
was higher in the Trop+ vs. Trop− group (Table 1b).
Comparing Trop+ to Trop− patients diagnosed with an ACS, the
medical therapy consisted of aspirin (93% vs. 84%, p b 0.01), clopidogrel
(63% vs. 53%, p b 0.01), prasugrel (13% vs. 3%, p b 0.01), ß-blocker (81% vs.
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Fig. 2. a: Distribution of minor chest emergencies. Except for PM= Peri/myocarditis all
other minor chest emergencies were found more frequently in the Trop− patients.
*p b 0.01. b: Interventions in the CPU. Percentage of Trop+ and Trop− patients
receiving an intervention in the CPU. *p b 0.01 between Trop+ vs. Trop− patients.
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Fig. 1. a: Symptoms on admission to CPU. Percentage of symptoms in Trop+ (n= 2853)
and Trop− (n= 8,803) patients admitted to CPU. *p b 0.01 for Trop+ vs. Trop− patients.
Multiple symptomswere possible. b: ECG in CPUpatients. ECG ﬁndings inpre-hospital and
CPU ECGs stratiﬁed for Trop+ (n= 2853) and Trop− (n = 8803) patients. *p b 0.01 for
Trop+ vs. Trop− patients.
Table 1b
Readmission characteristics at 3 month follow up. Characteristics of readmitted Trop+
and Trop− patients included in the German CPU Registry. Day of readmission is
presented with median and quartile. Number and length of readmission is presented as
mean and standard deviation.
Trop+ Trop− P
Readmission rate 28.9% 23.3 b0.01
Day of readmission 32 (4–61) 32 (8–67) 0.45
Cardiovascular reason 80.7% 70.0% b0.05
Number of readmissions 1.3 ± 0.6 1.2 ± 0.6 0.46
Length of readmission 9.8 ± 10.4 8.2 ± 10.4 b0.01
MACCE (revascularization or rehospitalization) 37.8% 27.5% b0.01
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66%, p b 0.01), ACE inhibitor (68% vs. 56%, p b 0.01), AT receptor blocker
(9% vs. 7%, p = 0.07), and statins (74% vs. 58%, p b 0.01).
Comparing Trop+ to Trop− patients after 3 months follow-up, the
medical therapy consisted of aspirin (83% vs. 55%, p b 0.01), clopidogrel
(53% vs.19%, p b 0.01), prasugrel (10% vs. 2%, p b 0.01), ß-blocker (83% vs.
65%, p b 0.01), ACE inhibitor (62% vs. 45%, p b 0.01), AT receptor blocker
(18% vs. 18%, p= 0.82), and statin (76% vs. 48%, p b 0.01).
We have collected prospective data from a number of clinics with a
CPU in Germany. Patients with chest pain apparently seem to beneﬁt
from the introduction of a chest pain unit because Trop+ patients
identiﬁed in the CPU were i) faster treated with PCI and ii) to a higher
percentage as compared to Trop− patients. iii) This lead to a low death
rate in the CPU as well as at 3 month follow up, also when compared to
data from the current guidelines [8] as well as from other CPUs [9].
An ECG in the preclinical setting is assessed rarely butmay by assessed
faster with novel ECG techniques in the future [10] and if a STEMI in a
patient is assessed, this patient should be transported directly to the
catheter lab, as urgently recommended by international guidelines,
instead of being transported to the CPU (or an emergency department)
before revascularization thereby saving important time [11].
More than half of the Trop+ patients underwent revascularization
by PCI, underlining the importance of a specialized CPU to identify
patients at risk for myocardial necrosis. In contrast, only a small
percentage of Trop− patients had PCI (18%). Time from hospital
admittance to invasive treatment was much shorter in Trop+ patients
underlining the importance of preparing the ground for speciﬁc
reperfusion therapy in a specialized CPU.
Nevertheless, Trop+ patients in the CPU were at a higher danger for
immediate and intermediate risk of death and MACCE than Trop−
patients. Trop+patients hadmore cardiovascular risk factors andmost of
them underwent a PCI. Therefore, a CPU may help to identify patients at
risk factors and facilitate optimized reperfusion therapy. Despite care by
cardiologists not all patients receive medical therapy following ESC
guidelines, and the rate of rehospitalization remains high. In summary,
quality improvement initiatives should identify reasons and correct the
causes of low adherence to the standard of care.
The registry is supported by the German Cardiac Society. Dr. Maier is
funded by the DFG (MA 1982/4-2, TPA03 SFB1002, GRK 1816 RP3) aswell
as the DZHK and the Fondation Leducq.
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